Whitefort Capital Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $43.8M | Buy |
3,882,000
+471,000
| +14% | +$5.31M | 12.84% | 2 |
|
2025
Q1 | $34.4M | Buy |
3,411,000
+1,020,000
| +43% | +$10.3M | 16.19% | 2 |
|
2024
Q4 | $28.3M | Hold |
2,391,000
| – | – | 13.54% | 2 |
|
2024
Q3 | $27.6M | Hold |
2,391,000
| – | – | 12.56% | 3 |
|
2024
Q2 | $25.3M | Hold |
2,391,000
| – | – | 15.58% | 2 |
|
2024
Q1 | $25.2M | Buy |
2,391,000
+800,000
| +50% | +$8.43M | 15.35% | 3 |
|
2023
Q4 | $17.9M | Buy |
+1,591,000
| New | +$17.9M | 11.39% | 3 |
|
2023
Q2 | – | Sell |
-833,471
| Closed | -$6.15M | – | 16 |
|
2023
Q1 | $6.15M | Sell |
833,471
-575,000
| -41% | -$4.24M | 5.72% | 5 |
|
2022
Q4 | $11.3M | Buy |
+1,408,471
| New | +$11.3M | 8.74% | 4 |
|